Public destination captured October 22, 2026. The reference retains the page layout and loaded imagery; shopping-extension UI is removed. Offers may change. No health answers were supplied.

Hers's treatment-range page opens with "Take control of your weight loss" and a pills-or-injections question, then asks about motivation and other health goals before showing priced medication cards, a Zepbound band, membership perks, a dosing schedule and a long FAQ. 1 ad in the Fluid library sends people here, a price-led static.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The hero repeats the ad's main cue right away: the announcement bar and the subline both lead with FDA-approved medications, and a product card shows the Wegovy Pill and Zepbound together. The first question (pills, injections or a provider recommendation) lets visitors start from the format they already prefer, and the next two prompts ask why they want to lose weight and what else they'd like GLP-1s to support, which keeps the opening personal without asking for health details. The medication cards are refreshingly direct, showing a "from" monthly price, the generic name and a safety link for each, and the fine print spells out the membership terms (the page says $39 for the first month, then $149 a month). The dosing section frames the slow start around reducing side effects, with an example chart and a four-step accordion from easing in to maintenance.
A green bar says FDA-approved GLP-1s are here with a See if you're eligible link, above a logo-only header.
A portrait and a product card sit beside a three-step indicator asking whether the visitor has a treatment in mind (GLP-1 pills, injections or a provider recommendation), answering "where do I start?"
A second question asks why the visitor wants to lose weight, with four answers from improving health to feeling better in their clothes.
A third question asks what else the visitor would like GLP-1s to support, such as heart health or craving control, with a not-sure option.
Under an FSA and HSA eligible tag and a line about no price markups, cards for the Wegovy Pill, Wegovy Pen, Zepbound Vial and Zepbound KwikPen show "from" monthly prices, generic names and safety links, answering "what will it cost?"
Small print explains that prices cover medication only and that an active membership is required, with its first-month and ongoing fees.
A full-bleed photo carries a weight-loss headline the page attributes to Zepbound with a See source link, three check bullets including once-weekly injection, and Get started.
A four-photo collage over five check rows (treatment plan, provider messaging, member community, partner discounts, smart scale) answers "what does the membership include?"
A headline about reaching goals while reducing side effects sits beside an example monthly dose chart and a four-step accordion, answering "how does treatment start?"
A long accordion covers membership cost, options, video visits, insurance, FSA and HSA, eligibility, switching from another GLP-1, how long to stay on it, dose changes and side effects.
The one ad captured for this page is a price-led static headlined "FDA-Approved". The page picks up the approval cue immediately, in the announcement bar and the hero subline, so the visitor knows they're in the right place. The price half of the promise takes longer to arrive: it waits until the medication cards, after three intake prompts, so the page asks for a little patience from someone who clicked expecting to see a number.
Captured from forhers.com in October 2026 for the Fluid Inspiration Library. Offers and prices change; this is what the page showed when we captured it.